Assessment of anti-PGL-I as a prognostic marker of leprosy reaction

International Journal of Leprosy

Volumn 66, Issue 3, 1998, Pages 356-364

  Stefani, Mariane M A ^a,d   Marteili, Celina M T ^a   Morais Neto, Otaliba L ^a   Marteili, Pierpaolo ^a   Costa, Mauricio B ^b   De Andrade, Ana Lucia S S ^c  

^a Department of Immunology ^*

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c PAN AMERICAN HEALTH ORGANIZATION   (United States)

^d Setor Universitario   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; GLYCOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEPROSY; LEPROSY CONTROL; LIPID ANALYSIS; MALE; PROGNOSIS; SERODIAGNOSIS;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEPROSY; MALE; MYCOBACTERIUM LEPRAE; PROGNOSIS;

EID: 0032435425     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BACH, M.-A., WALLACH, D., FLAGUEL, B., HOFFENBACH, A. and COTTENTOT, A. Antibodies to phenolic glycolipid-I in leprosy patients - evolution under chemotherapy. Int. J. Lepr. 54 (1986) 256-267.
2. BAUMGART, K. W., BRITTON, W. J., MULLINS, R. J., BASTEN, A. and ARNETSON, R. C. Subclinical infection with Mycobacterium leprae - a problem for leprosy control strategies. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 412-415.
3. BRENNAN, P. J. and BARROW, W. W. Evidence for species-specific lipid antigen in Mycobacterium leprae. Int. J. Lepr. 48 (1980) 382-387.
4. BRETT, S. J., PAYNE, E. N., GIGG, J., BURGESS, P. and GIGG, R. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid-I in the serology of leprosy. Clin. Exp. Immunol. 64 (1986) 476-483.
5. BURGESS, P. J., FINE, P. E. M., PONNIGHAUS, J. M. and DRAPER, C. Serological tests in leprosy; the sensitivity, specificity and predictive value of ELISA tests based on phenolic glycolipid antigens, and the implications for their use in epidemiological studies. Epidemiol. Infect. 101 (1988) 159-171.
6. CHO, S.-N., YANAGIHARA, D. L., HUNTER, S. W., GELBER, R. W. and BRENNAN, P. J. Serological specificity of phenolic glycolipid-I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect. Immun. 41 (1983) 1077-1083.
7. CHOUDHURI, K. The immunology of leprosy; unraveling an enigma. Int. J. Lepr. 63 (1995) 430-447.
8. FINE, P. E. M., PONNIGHAUS, J. M., BURGESS, P., CLARKSON, J. A. and DRAPER, C. C. Seroepidemiological studies of leprosy in northern Malawi based on an enzyme-linked immunosorbent assay using synthetic glycoconjugate antigen. Int. J. Lepr. 56 (1988) 243-254.
9. FINE, P. E. M., STERNE, J. A. C., PONNIGHAUS, J. M. and REES, R. J. W. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344 (1994) 1245-1249.
10. FOSS, N. T., CALLERA, F. and ALBERTO, F. L. Anti-PGL-I levels in leprosy patients and their contacts. Bras. J. Med. Biol. Res. 26 (1993) 43-51.
11. GONZÁLEZ-ABREU, E., PON, J. A., HERNÁNDEZ, P., RODRIGUEZ, J., MENDOZA, E., HERNÁNDEZ, M., CUEVAS, E. and GONZÁLEZ, A. B. Serological reactivity to a synthetic analog of phenolic glycolipid-I and early detection of leprosy in an area of low endemicity. Lepr. Rev. 67 (1996) 4-12.
12. HENNECKENS, J. L. and BURING, J. E. Epidemiology in Medicine. 5th ed. Boston: Little, Brown and Company, 1987.
13. HOAGLIN, D. C., MOSTELLER, F. and TUKEY, J. W. Understanding Robust and Exploratory Data Analysis. New York: John Wiley & Sons, 1983.
14. HUSSAIN, R., KIFAYET, A. and CHIANG, T. J. Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect. Immun. 63 (1995) 410-415.
15. KAUFMANN, S. H. E. Immunity to intracellular bacteria. In: Fundamental Immunology. Paul, W. E., ed. New York: Raven Press Ltd , 1993, pp. 1251-1286.
16. KIFAYET, A. and HUSSAIN, R. IgG subclasses recognition pattern in leprosy: recognition of M. leprae antigen by IgG1 and IgG3 antibodies is distinct across the disease spectrum. Int. J Lepr. 64 (1996) 69-78.
17. KLATSER, P. R. Serology of leprosy. Trop. Geogr. Med. 46 (1994) 115-118.
18. KLATSER, P. R., JANSON, A. M., THOLE, J. E. R., BUHRER, S., BOS, C., SOEBONO, H. and DE VRIES, R. R. P. Humoral and cellular immune reactivity to recombinant M leprae antigens in HLA-typed leprosy patients and healthy controls. Int. J. Lepr. 65 (1997) 178-189.
19. LIENHARDT, C. and FINE, P. E. M. Type I reaction, neuritis and disability in leprosy. What is the current epidemiological situation? Lepr. Rev. 65 (1994) 9-33.
20. MARTFLLI, C. M. T., MORAES NETO, O. L., ANDRADE, A. L. S. S., SILVA, S. A., SILVA, I. M. and ZICKER, F. Spatial patterns of leprosy in an urban area in central Brazil. Bull. WHO 73 (1995) 315-319.
21. MEEKER, H. C., SCHULLER-LEVIS, G., FUSCO, F., GIARDINA-BECKET, M. A., SERSEN, E. and LEVIS, W R. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I and mycobacterial lipoarabinomannan. Int. J. Lepr. 58 (1990) 503-511.
22. MOODY, D. D., SUGITA, M., PETERS, P. J., BRENNER, M. B. and PORCELLI, S. A. The CD1 restricted T-cell response to mycobacteria. Res Immunol. 147 Suppl. (1996) 550-559.
23. NOORDEEN, S. K. Eliminating leprosy as a public health problem; why the optimism is justified. Int. J. Lepr. 63 (1995) 559-566.
24. OTTENHOFF, T. H. M. Immunology of leprosy: lessons from and for leprosy. Int. J. Lepr. 62 (1994) 108-121.
25. REED, G. F., MEADE, B. D. and STEINHOFF, M. C. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 96 (1995) 600-603.
26. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
27. ROCHE, P. W., LE MASTER, J. and BUTLIN, R. Risk factors for type 1 reactions in leprosy. Int. J. Lepr. 65 (1997) 450-455.
28. ROCHE, P. W., THEUVENET, J. W. and BRITTON, W. J. Risk factors for type 1 reactions in borderline leprosy patients. Lancet 338 (1991) 654-657.
29. SAAD, M. H. F., MEDEIROS, M. A., GALLO, M. E. N. and FONSECA, L. S. Use of the anti-PGL-I antibody ELISA and the Mitsuda reaction in early diagnosis of leprosy. Bras. J. Med. Biol. Res. 24 (1991) 801-805.
30. SAHA, K., CHATTOPADHYA, D., KASHYUP, A., AGARWAL, U. and CHAKRABARTY, S. K. Enhanced response of serum IgG class of anti-PGL-I antibodies in leprosy patients during onset and following clinical remission of type 1 and type 2 reactions. Int. J. Lepr. 63 (1995) 105-109.
31. SCOLLARD, D. M. Time and change: new dimensions in the immunopathologic spectrum of leprosy. Ann. Soc. Belg. Med. Trop. 73 Suppl. 1 (1993) 5-11.
32. ULRICH, M , SMITH, P. G., SAMPSON, C., ZUNIGA, M., CENTENO, M., GARCIA, V., MANRIQUE, X., SALGADO, A. and CONVIT, J. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Int. J. Lepr. 59 (1991) 405-415.
33. VAN BRAKEL, W. H., KHAWAS, I. B. and LUCAS, S. B. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal. Lepr. Rev. 65 (1994) 190-203.
34. YAMAMURA, M., UYEMURA, K., DEANS, R. J., WEINBERG, K., REA, T. H., BLOOM, B. R. and MODLIN, R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254 (1991) 277-279.